Close
May 2, 2024 07:32AM
May 2, 2024 07:30AM
May 2, 2024 07:00AM
May 2, 2024 06:04AM
May 1, 2024 09:01AM
May 1, 2024 08:46AM
May 1, 2024 08:36AM SELLAS Life Sciences (SLS) Reports Positive Phase 2 Preliminary Data of SLS009
May 1, 2024 08:32AM
May 1, 2024 08:31AM
May 1, 2024 08:04AM
May 1, 2024 08:02AM
May 1, 2024 07:16AM
May 1, 2024 06:27AM
Apr 30, 2024 05:12PM Neurocrine Biosciences (NBIX) Announces FDA Approval of INGREZZA SPRINKLE Capsules
Apr 30, 2024 03:21PM
Apr 30, 2024 09:04AM
Apr 30, 2024 08:33AM
Apr 30, 2024 08:31AM
Apr 30, 2024 08:07AM
Apr 30, 2024 08:06AM
Apr 30, 2024 08:03AM INmune Bio (INMB) Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro Under Compassionate Use for Over Three Years
Apr 30, 2024 08:01AM
Apr 30, 2024 07:31AM
Apr 30, 2024 07:07AM
Apr 30, 2024 07:07AM
Apr 30, 2024 07:04AM
Apr 30, 2024 07:02AM
Apr 30, 2024 06:39AM Immunic Inc. (IMUX) phase 2 EMPhASIS trial data published in Neurology Neuroimmunology & Neuroinflammation
Apr 30, 2024 06:31AM
Apr 29, 2024 06:55PM
Apr 29, 2024 04:07PM
Apr 29, 2024 10:21AM
Apr 29, 2024 10:11AM
Apr 29, 2024 09:59AM
Apr 29, 2024 09:39AM Immix Biopharma (IMMX) Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
Apr 29, 2024 09:02AM
Apr 29, 2024 09:01AM
Apr 29, 2024 09:00AM
Apr 29, 2024 08:45AM
Apr 29, 2024 08:02AM
Apr 29, 2024 08:02AM
Apr 29, 2024 08:01AM Soleno Therapeutics (SLNO) Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
Apr 29, 2024 08:01AM
Apr 29, 2024 08:00AM
Apr 29, 2024 07:58AM
Apr 29, 2024 07:42AM
Apr 29, 2024 07:32AM
Apr 29, 2024 07:06AM
Apr 29, 2024 07:05AM Prime Medicine (PRME) announces fda clearance of investigational new drug (ind) application for pm359 for the treatment of chronic granulomatous disease
Apr 29, 2024 07:03AM

66,958 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.